Cosmos Pharmaceutical Stock Return On Equity
COSMOS Pharmaceutical fundamentals help investors to digest information that contributes to COSMOS Pharmaceutical's financial success or failures. It also enables traders to predict the movement of COSMOS Pink Sheet. The fundamental analysis module provides a way to measure COSMOS Pharmaceutical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to COSMOS Pharmaceutical pink sheet.
COSMOS |
COSMOS Pharmaceutical Company Return On Equity Analysis
COSMOS Pharmaceutical's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current COSMOS Pharmaceutical Return On Equity | 0.12 |
Most of COSMOS Pharmaceutical's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, COSMOS Pharmaceutical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, COSMOS Pharmaceutical has a Return On Equity of 0.122. This is 100.51% lower than that of the Healthcare sector and significantly higher than that of the Pharmaceutical Retailers industry. The return on equity for all United States stocks is 139.35% lower than that of the firm.
COSMOS Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses COSMOS Pharmaceutical's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of COSMOS Pharmaceutical could also be used in its relative valuation, which is a method of valuing COSMOS Pharmaceutical by comparing valuation metrics of similar companies.COSMOS Pharmaceutical is currently under evaluation in return on equity category among its peers.
COSMOS Fundamentals
| Return On Equity | 0.12 | |||
| Return On Asset | 0.0521 | |||
| Profit Margin | 0.03 % | |||
| Operating Margin | 0.04 % | |||
| Current Valuation | 3.89 B | |||
| Shares Outstanding | 39.6 M | |||
| Shares Owned By Insiders | 51.47 % | |||
| Shares Owned By Institutions | 20.75 % | |||
| Price To Book | 2.72 X | |||
| Price To Sales | 0.01 X | |||
| Revenue | 755.41 B | |||
| Gross Profit | 151.45 B | |||
| EBITDA | 48.21 B | |||
| Net Income | 23.16 B | |||
| Total Debt | 3 B | |||
| Book Value Per Share | 5,056 X | |||
| Cash Flow From Operations | 32.19 B | |||
| Earnings Per Share | 4.54 X | |||
| Number Of Employees | 5.1 K | |||
| Beta | 0.26 | |||
| Market Capitalization | 3.89 B | |||
| Total Asset | 363.05 B | |||
| Z Score | 2.6 | |||
| Annual Yield | 0.01 % | |||
| Net Asset | 363.05 B | |||
| Last Dividend Paid | 40.0 |
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Consideration for investing in COSMOS Pink Sheet
If you are still planning to invest in COSMOS Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the COSMOS Pharmaceutical's history and understand the potential risks before investing.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |